Immunovant, Inc.
IMVTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Immunovant, Inc. Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Mar 31, 2026. The latest insider filing shown is dated Jun 26, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Immunovant, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-26 · Stout Jay S: Larger than 144 of the 145 other insider sales of Common Stock on file. SEC filing
- 2026-06-26 · Gloria Melanie: Larger than 135 of the 145 other insider sales of Common Stock on file. SEC filing
- 2026-06-26 · Van Tuyl Christopher: Larger than 136 of the 145 other insider sales of Common Stock on file. SEC filing
- 2026-05-28 · Fromkin Andrew J.: Larger than all 145 other insider sales of Common Stock on file. SEC filing
- 2026-04-23 · Girao Tiago: Larger than 141 of the 145 other insider sales of Common Stock on file. SEC filing
- 2026-04-02 · Venker Eric: Larger than 131 of the 145 other insider sales of Common Stock on file. SEC filing
- 2025-12-01 · Hughes Douglas J.: Larger than 132 of the 145 other insider sales of Common Stock on file. SEC filing
- 2025-12-01 · Fromkin Andrew J.: Larger than 140 of the 145 other insider sales of Common Stock on file. SEC filing
- 2025-04-09 · Salzmann Peter: Larger than 143 of the 145 other insider sales of Common Stock on file. SEC filing
- 2025-02-19 · Salzmann Peter: Larger than 137 of the 145 other insider sales of Common Stock on file. SEC filing
- 2024-11-20 · Salzmann Peter: Larger than 139 of the 145 other insider sales of Common Stock on file. SEC filing
- 2024-08-21 · Salzmann Peter: Larger than 134 of the 145 other insider sales of Common Stock on file. SEC filing
- 2024-05-22 · Salzmann Peter: Larger than 138 of the 145 other insider sales of Common Stock on file. SEC filing
- 2024-04-17 · Salzmann Peter: Larger than 142 of the 145 other insider sales of Common Stock on file. SEC filing
- 2024-02-22 · Salzmann Peter: Larger than 133 of the 145 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-26 | Van Tuyl Christopher · Chief Legal Officer | Common Stock | S — Open market or private sale | −14,982 | 38.19 | SEC filing |
| 2026-06-26 | Pande Atul · Director | Common Stock | S — Open market or private sale | −1,500 | 38.01 | SEC filing |
| 2026-06-26 | Gloria Melanie · Chief Operating Officer | Common Stock | S — Open market or private sale | −14,748 | 38.18 | SEC filing |
| 2026-06-26 | Gloria Melanie · Chief Operating Officer | Common Stock | S — Open market or private sale | −2,966 | 38.95 | SEC filing |
| 2026-06-26 | Stout Jay S · Chief Technology Officer | Common Stock | S — Open market or private sale | −33,277 | 38.18 | SEC filing |
| 2026-06-26 | Girao Tiago · Chief Financial Officer | Common Stock | S — Open market or private sale | −10,000 | 38.46 | SEC filing |
| 2026-06-26 | Stout Jay S · Chief Technology Officer | Common Stock | S — Open market or private sale | −6,723 | 38.94 | SEC filing |
| 2026-06-26 | Van Tuyl Christopher · Chief Legal Officer | Common Stock | S — Open market or private sale | −2,842 | 38.96 | SEC filing |
Showing 8 of 12 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-26 | Van Tuyl Christopher · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +17,824 | SEC filing |
| 2026-06-26 | Pande Atul · Director | Common Stock | M — Exercise or conversion of derivative security | +1,500 | SEC filing |
| 2026-06-26 | Girao Tiago · Chief Financial Officer | Common Stock | M — Exercise or conversion of derivative security | +10,000 | SEC filing |
| 2026-06-26 | Pande Atul · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −1,500 | SEC filing |
| 2026-06-26 | Van Tuyl Christopher · Chief Legal Officer | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −17,824 | SEC filing |
| 2026-06-26 | Girao Tiago · Chief Financial Officer | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −10,000 | SEC filing |
| 2026-06-15 | Pande Atul · Director | Common Stock | M — Exercise or conversion of derivative security | +1,500 | SEC filing |
| 2026-06-15 | Pande Atul · Director | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −1,500 | SEC filing |
Showing 8 of 20 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-01 | Venker Eric · Chief Executive Officer | Common Stock | D — Disposition to the issuer | −334,960 | SEC filing |
Showing 1 of 1 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.